HomeCompareXBI vs SBUX

XBI vs SBUX: Dividend Comparison 2026

XBI yields 0.34% · SBUX yields 2.75%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SBUX wins by $137.4K in total portfolio value
10 years
XBI
XBI
● Live price
0.34%
Share price
$127.73
Annual div
$0.44
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.2K
Annual income
$35.27
Full XBI calculator →
SBUX
SBUX
● Live price
2.75%
Share price
$89.59
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$157.5K
Annual income
$65,840.13
Full SBUX calculator →

Portfolio growth — XBI vs SBUX

📍 SBUX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodXBISBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, XBI + SBUX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
XBI pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

XBI
Annual income on $10K today (after 15% tax)
$29.31/yr
After 10yr DRIP, annual income (after tax)
$29.98/yr
SBUX
Annual income on $10K today (after 15% tax)
$233.40/yr
After 10yr DRIP, annual income (after tax)
$55,964.11/yr
At 15% tax rate, SBUX beats the other by $55,934.13/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of XBI + SBUX for your $10,000?

XBI: 50%SBUX: 50%
100% SBUX50/50100% XBI
Portfolio after 10yr
$88.8K
Annual income
$32,937.70/yr
Blended yield
37.08%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

XBI
Analyst Ratings
1
Hold
Consensus: Hold
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+16.1% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

XBI buys
0
SBUX buys
0
No recent congressional trades found for XBI or SBUX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricXBISBUX
Forward yield0.34%2.75%
Annual dividend / share$0.44$2.46
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%48.3%
Portfolio after 10y$20.2K$157.5K
Annual income after 10y$35.27$65,840.13
Total dividends collected$349.00$127.5K
Payment frequencyquarterlyquarterly
SectorETFConsumer Discretionary
Analyst consensusHoldBuy

Year-by-year: XBI vs SBUX ($10,000, DRIP)

YearXBI PortfolioXBI Income/yrSBUX PortfolioSBUX Income/yrGap
1← crossover$10,734$34.49$11,107$407.21$373.00SBUX
2$11,521$34.60$12,512$626.87$991.00SBUX
3$12,362$34.70$14,366$978.69$2.0KSBUX
4$13,262$34.80$16,929$1,557.50$3.7KSBUX
5$14,225$34.89$20,658$2,543.80$6.4KSBUX
6$15,256$34.98$26,406$4,302.22$11.2KSBUX
7$16,359$35.06$35,877$7,622.00$19.5KSBUX
8$17,539$35.13$52,741$14,352.64$35.2KSBUX
9$18,802$35.20$85,676$29,243.03$66.9KSBUX
10$20,153$35.27$157,513$65,840.13$137.4KSBUX

XBI vs SBUX: Complete Analysis 2026

XBIETF

The State Street SPDR S&P Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index (the "Index")Seeks to provide exposure to the Biotechnology segment of the S&P TMI, which comprises the following sub-industries: BiotechnologySeeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocksAllows investors to take strategic or tactical positions at a more targeted level than traditional sector based investing

Full XBI Calculator →

SBUXConsumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this XBI vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

XBI vs SCHDXBI vs JEPIXBI vs OXBI vs KOXBI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.